what are the Recommendations for HF and Pregnancy
Referenced studies that support the recommendations are summa-
rized in the Online Data Supplements.?
In women with HF or cardiomyopathy who are pregnant or currently planning for pregnancy, ACEi, ARB, ARNi, MRA, SGLT2i, ivabradine, and vericiguat should not be administered because of significant risks of fetal harm.